{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:13:59Z","timestamp":1790284439802,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["56\/9\/2015-BMS"],"award-info":[{"award-number":["56\/9\/2015-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s11033-022-07973-2","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T18:56:30Z","timestamp":1667415390000},"page":"235-244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Over expression of mTOR gene predicts overall survival in myelodysplastic syndromes"],"prefix":"10.1007","volume":"50","author":[{"given":"Nehakumari","family":"Maurya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purvi","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purvi","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrakala","family":"Shanmukhaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4783-2691","authenticated-orcid":false,"given":"Babu Rao","family":"Vundinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"issue":"14","key":"7973_CR1","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1056\/NEJMra1904794","volume":"383","author":"M Cazzola","year":"2020","unstructured":"Cazzola M (2020) Myelodysplastic Syndromes. N Engl J Med 383(14):1358\u20131374. https:\/\/doi.org\/10.1056\/NEJMra1904794","journal-title":"N Engl J Med"},{"issue":"23","key":"7973_CR2","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1182\/blood-2009-08-236422","volume":"114","author":"K Sridhar","year":"2009","unstructured":"Sridhar K, Ross DT, Tibshirani R, Butte AJ, Greenberg PL (2009) Relationship of differential gene expression profiles in CD34 + myelodysplastic syndrome marrow cells to disease subtype and progression. Blood 114(23):4847\u20134858. https:\/\/doi.org\/10.1182\/blood-2009-08-236422","journal-title":"Blood"},{"issue":"12","key":"7973_CR3","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL et al (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120(12):2454\u20132465. https:\/\/doi.org\/10.1182\/blood-2012-03-420489","journal-title":"Blood"},{"issue":"6","key":"7973_CR4","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89(6):2079\u20132088","journal-title":"Blood"},{"issue":"4","key":"7973_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41408-018-0074-7","volume":"8","author":"HA Hou","year":"2018","unstructured":"Hou HA, Tsai CH, Lin CC, Chou WC, Kuo YY, Liu CY, Tseng MH, Peng YL, Liu MC, Liu CW, Liao XW, Lin LI, Yao M, Tang JL, Tien HF (2018) Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome. Blood cancer journal 8(4):39. https:\/\/doi.org\/10.1038\/s41408-018-0074-7","journal-title":"Blood cancer journal"},{"issue":"2","key":"7973_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/cas.14270","volume":"111","author":"L Jiang","year":"2020","unstructured":"Jiang L, Luo Y, Zhu S, Wang L, Ma L, Zhang H, Shen C, Yang W, Ren Y, Zhou X, Mei C, Ye L, Xu W, Yang H, Lu C, Jin J, Tong H (2020) Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes. Cancer Sci 111(2):580\u2013591. https:\/\/doi.org\/10.1111\/cas.14270","journal-title":"Cancer Sci"},{"issue":"1","key":"7973_CR7","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1038\/s41598-022-09864-9","volume":"12","author":"N Maurya","year":"2022","unstructured":"Maurya N, Mohanty P, Dhangar S, Panchal P, Jijina F, Mathan S, Shanmukhaiah C, Madkaikar M, Vundinti BR (2022) Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes. Sci Rep 12(1):5925. https:\/\/doi.org\/10.1038\/s41598-022-09864-9","journal-title":"Sci Rep"},{"issue":"2","key":"7973_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/leu.2013.336","volume":"28","author":"T Haferlach","year":"2014","unstructured":"Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, Schnittger S, Sanada M, Kon A, Alpermann T, Yoshida K, Roller A, Nadarajah N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler HP, Klein HU, Dugas M, Ogawa S (2014) Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 28(2):241\u2013247. https:\/\/doi.org\/10.1038\/leu.2013.336","journal-title":"Leukemia"},{"issue":"6","key":"7973_CR9","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.3892\/ol.2019.11040","volume":"18","author":"S Lv","year":"2019","unstructured":"Lv S, Xu X, Wu Z (2019) Identification of key candidate genes and pathways in endometrial cancer: Evidence from bioinformatics analysis. Oncol Lett 18(6):6679\u20136689. https:\/\/doi.org\/10.3892\/ol.2019.11040","journal-title":"Oncol Lett"},{"issue":"2","key":"7973_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1182\/blood-2004-12-4633","volume":"108","author":"CS Wilson","year":"2006","unstructured":"Wilson CS, Davidson GS, Martin SB, Andries E, Potter J, Harvey R, Ar K, Xu Y, Kopecky KJ, Ankerst DP, Gundacker H, Slovak ML, Mosquera-Caro M, Chen IM, Stirewalt DL, Murphy M, Schultz FA, Kang H, Wang X, Radich JP, Willman CL (2006) Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction. Blood 108(2):685\u2013696. https:\/\/doi.org\/10.1182\/blood-2004-12-4633","journal-title":"Blood"},{"issue":"3","key":"7973_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3892\/ijo.2017.4233","volume":"52","author":"L Handschuh","year":"2018","unstructured":"Handschuh L, Ka\u017amierczak M, Milewski MC, G\u00f3ralski M, \u0141uczak M, Wojtaszewska M, Uszczy\u0144ska-Ratajczak B, Lewandowski K, Komarnicki M, Figlerowicz M (2018) Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR. Int J Oncol 52(3):656\u2013678. https:\/\/doi.org\/10.3892\/ijo.2017.4233","journal-title":"Int J Oncol"},{"key":"7973_CR12","doi-asserted-by":"publisher","unstructured":"Garza-Veloz I, Martinez-Fierro ML, Jaime-Perez JC, Carrillo-Sanchez K, Ramos-Del Hoyo MG, Lugo-Trampe A, Rojas-Martinez A, Gutierrez-Aguirre CH, Gonzalez-Llano O, Salazar-Riojas R, Hidalgo-Miranda A, Gomez-Almaguer D, Ortiz-Lopez R (2015) Identification of differentially expressed genes associated with prognosis of B acute lymphoblastic leukemia. Disease markers, 2015, 828145. https:\/\/doi.org\/10.1155\/2015\/828145","DOI":"10.1155\/2015\/828145"},{"issue":"19","key":"7973_CR13","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, L\u00f8nning PE, B\u00f8rresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869\u201310874. https:\/\/doi.org\/10.1073\/pnas.191367098","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"7973_CR14","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1182\/blood-2017-05-783050","volume":"130","author":"Y Shiozawa","year":"2017","unstructured":"Shiozawa Y, Malcovati L, Gall\u00ec A, Pellagatti A, Karimi M, Sato-Otsubo A, Sato Y, Suzuki H, Yoshizato T, Yoshida K, Shiraishi Y, Chiba K, Makishima H, Boultwood J, Hellstr\u00f6m-Lindberg E, Miyano S, Cazzola M, Ogawa S (2017) Gene expression and risk of leukemic transformation in myelodysplasia. Blood 130(24):2642\u20132653. https:\/\/doi.org\/10.1182\/blood-2017-05-783050","journal-title":"Blood"},{"issue":"3","key":"7973_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/cancers13030481","volume":"13","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Eveillard JR, Couturier MA, Soubise B, Chen JM, Gao S, Basinko A, Morel F, Douet-Guilbert N, Troadec MB (2021) Asian Population Is More Prone to Develop High-Risk Myelodysplastic Syndrome, Concordantly with Their Propensity to Exhibit High-Risk Cytogenetic Aberrations. Cancers 13(3):481. https:\/\/doi.org\/10.3390\/cancers13030481","journal-title":"Cancers"},{"issue":"W1","key":"7973_CR16","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, Imamichi T, Chang W (2022) DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res 50(W1):W216\u2013W221 Advance online publication. https:\/\/doi.org\/10.1093\/nar\/gkac194","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"7973_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"d Huang","year":"2009","unstructured":"Huang d, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211","journal-title":"Nat Protoc"},{"issue":"1","key":"7973_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/nar\/gkg034","volume":"31","author":"C von Mering","year":"2003","unstructured":"von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B (2003) STRING: a database of predicted functional associations between proteins. Nucleic Acids Res 31(1):258\u2013261. https:\/\/doi.org\/10.1093\/nar\/gkg034","journal-title":"Nucleic Acids Res"},{"key":"7973_CR19","doi-asserted-by":"publisher","unstructured":"Graubert T, Walter MJ (2011) Genetics of myelodysplastic syndromes: new insights. Hematology. American Society of Hematology. Education Program, 2011, 543\u2013549. https:\/\/doi.org\/10.1182\/asheducation-2011.1.543","DOI":"10.1182\/asheducation-2011.1.543"},{"issue":"22","key":"7973_CR20","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","volume":"122","author":"E Papaemmanuil","year":"2013","unstructured":"Papaemmanuil E, Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium et al (2013) Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122(22):3616\u20133699. https:\/\/doi.org\/10.1182\/blood-2013-08-518886","journal-title":"Blood"},{"issue":"6","key":"7973_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1600-0609.2005.00551.x","volume":"75","author":"G Stifter","year":"2005","unstructured":"Stifter G, Heiss S, Gastl G, Tzankov A, Stauder R (2005) Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis. Eur J Haematol 75(6):485\u2013491. https:\/\/doi.org\/10.1111\/j.1600-0609.2005.00551.x","journal-title":"Eur J Haematol"},{"issue":"3","key":"7973_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.stem.2019.05.019","volume":"25","author":"M Yamashita","year":"2019","unstructured":"Yamashita M, Passegu\u00e9 E (2019) TNF-\u03b1 Coordinates Hematopoietic Stem Cell Survival and Myeloid Regeneration. Cell Stem Cell 25(3):357\u2013372e7. https:\/\/doi.org\/10.1016\/j.stem.2019.05.019","journal-title":"Cell Stem Cell"},{"issue":"11","key":"7973_CR23","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1038\/s41375-018-0131-z","volume":"32","author":"WL Heaton","year":"2018","unstructured":"Heaton WL, Senina AV, Pomicter AD, Salama ME, Clair PM, Yan D, Bell RN, Gililland JM, Prchal JT, O\u2019Hare T, Deininger MW (2018) Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion. Leukemia 32(11):2399\u20132411. https:\/\/doi.org\/10.1038\/s41375-018-0131-z","journal-title":"Leukemia"},{"key":"7973_CR24","doi-asserted-by":"publisher","unstructured":"Tian T, Wang M, Ma D (2014) TNF-\u03b1, a good or bad factor in hematological diseases?. Stem cell investigation, 1, 12. https:\/\/doi.org\/10.3978\/j.issn.2306-9759.2014.04.02","DOI":"10.3978\/j.issn.2306-9759.2014.04.02"},{"issue":"1","key":"7973_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/cvr\/cvp166","volume":"84","author":"G Kewalramani","year":"2009","unstructured":"Kewalramani G, Puthanveetil P, Wang F, Kim MS, Deppe S, Abrahani A, Luciani DS, Johnson JD, Rodrigues B (2009) AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death. Cardiovascular Res 84(1):42\u201353. https:\/\/doi.org\/10.1093\/cvr\/cvp166","journal-title":"Cardiovascular Res"},{"key":"7973_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","volume":"10","author":"Z Zou","year":"2020","unstructured":"Zou Z, Tao T, Li H, Zhu X (2020) mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell & bioscience 10:31. https:\/\/doi.org\/10.1186\/s13578-020-00396-1","journal-title":"Cell & bioscience"},{"issue":"8","key":"7973_CR27","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.3390\/ijms19082396","volume":"19","author":"S Mirabilii","year":"2018","unstructured":"Mirabilii S, Ricciardi MR, Piedimonte M, Gianfelici V, Bianchi MP, Tafuri A (2018) Biological Aspects of mTOR in Leukemia. Int J Mol Sci 19(8):2396. https:\/\/doi.org\/10.3390\/ijms19082396","journal-title":"Int J Mol Sci"},{"key":"7973_CR28","doi-asserted-by":"publisher","first-page":"611690","DOI":"10.3389\/fonc.2020.611690","volume":"10","author":"Y Feng","year":"2021","unstructured":"Feng Y, Chen X, Cassady K, Zou Z, Yang S, Wang Z, Zhang X (2021) The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside. Front Oncol 10:611690. https:\/\/doi.org\/10.3389\/fonc.2020.611690","journal-title":"Front Oncol"},{"key":"7973_CR29","doi-asserted-by":"publisher","unstructured":"Cell reports, 11(9), 1446\u20131457. https:\/\/doi.org\/10.1016\/j.celrep.2015.04.063","DOI":"10.1016\/j.celrep.2015.04.063"},{"issue":"5","key":"7973_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1365-2141.2005.05360.x","volume":"128","author":"U Platzbecker","year":"2005","unstructured":"Platzbecker U, Haase M, Herbst R, H\u00e4nel A, Voigtmann K, Thiede CH, Mohr B, Schleyer E, Leopold T, Orth M, H\u00e4nel M, Ehninger G, Bornh\u00e4user M (2005) Activity of sirolimus in patients with myelodysplastic syndrome\u2013results of a pilot study. Br J Haematol 128(5):625\u2013630. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05360.x","journal-title":"Br J Haematol"},{"issue":"5","key":"7973_CR31","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/bjh.14345","volume":"175","author":"M Wermke","year":"2016","unstructured":"Wermke M, Schuster C, Nolte F, Al-Ali HK, Kiewe P, Sch\u00f6nefeldt C, Jakob C, von Bonin M, Hentschel L, Klut IM, Ehninger G, Bornh\u00e4user M, Baretton G, Germing U, Herbst R, Haase D, Hofmann WK, Platzbecker U (2016) Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS). Br J Haematol 175(5):917\u2013924. https:\/\/doi.org\/10.1111\/bjh.14345","journal-title":"Br J Haematol"},{"issue":"2","key":"7973_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10238-017-0478-x","volume":"18","author":"A Khanna","year":"2018","unstructured":"Khanna A, Bhushan B, Chauhan PS, Saxena S, Gupta DK, Siraj F (2018) High mTOR expression independently prognosticates poor clinical outcome to induction chemotherapy in acute lymphoblastic leukemia. Clin experimental Med 18(2):221\u2013227. https:\/\/doi.org\/10.1007\/s10238-017-0478-x","journal-title":"Clin experimental Med"},{"issue":"10","key":"7973_CR33","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/leu.2010.167","volume":"24","author":"H Makishima","year":"2010","unstructured":"Makishima H, Jankowska AM, Tiu RV, Szpurka H, Sugimoto Y, Hu Z, Saunthararajah Y, Guinta K, Keddache MA, Putnam P, Sekeres MA, Moliterno AR, List AF, McDevitt MA, Maciejewski JP (2010) Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia 24(10):1799\u20131804. https:\/\/doi.org\/10.1038\/leu.2010.167","journal-title":"Leukemia"},{"issue":"8","key":"7973_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/ng.620","volume":"42","author":"G Nikoloski","year":"2010","unstructured":"Nikoloski G, Langemeijer SM, Kuiper RP, Knops R, Massop M, T\u00f6nnissen ER, van der Heijden A, Scheele TN, Vandenberghe P, de Witte T, van der Reijden BA, Jansen JH (2010) Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat Genet 42(8):665\u2013667. https:\/\/doi.org\/10.1038\/ng.620","journal-title":"Nat Genet"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07973-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07973-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07973-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T16:44:53Z","timestamp":1674924293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07973-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["7973"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07973-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"assertion":[{"value":"23 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent:"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Ethics Committee for research on Human subjects of National Institute of Immunohematology and with the 1964 Helsinki declaration and its later amendments.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}